Adjuvant immunotherapy with transfer factor in patients with melanoma metastatic to lung
- 1 January 1980
Abstract
Nine patients with resectable pulmonary metastases of malignant melanoma were treated with surgery and transfer factor. Twelve months after thoractomy, all were alive. After a median follow-up of 20 mo., only 1 patient died. Historic, other-center controls treated with surgery alone had a significantly (P < 0.025) lower survival rate. Recurrence rates tended to be lower in the transfer factor group, but the differences were not significant. Transfer factor may prolong survival in patients with an immunologically responsive malignancy and a small residual tumor burden.This publication has 1 reference indexed in Scilit: